Organovo Holdings Depreciation & Amortization 2011-2026 | ONVO

Annual Depreciation & Amortization Organovo Holdings

2025	2024	2023	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
266 K	280 K	293 K	41 K	1.14 M	980 K	1.27 M	1.15 M	815 K	472 K	387 K	-	195 K	68 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.27 M	41 K	566 K

Quarterly Depreciation & Amortization Organovo Holdings

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	61 K	-	-	-	70 K	-	-	-	67 K	-	-	234 K	50 K	-	-	96 K	59 K	-	-	18 K	8 K	4 K	-	1.14 M	379 K	205 K	-	824 K	570 K	-	-	-	326 K	-	-	824 K	502 K	-	-	560 K	324 K	-	-	334 K	208 K	-	-	288 K	190 K	80 K	-	178 K	100 K	17 K	-	49.9 K	32.4 K	15.6 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.14 M	4 K	252 K

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Agilent Technologies A	321 M	$ 118.25	-1.27 %	$ 35.9 B	USA
Burning Rock Biotech Limited BNR	47.8 M	$ 22.5	9.44 %	$ 242 M	China
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
CareDx, Inc CDNA	15 M	$ 22.42	27.6 %	$ 1.19 B	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	1.11 M	$ 1.46	2.82 %	$ 1.94 M	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Castle Biosciences CSTL	16 M	$ 24.56	-0.24 %	$ 682 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Charles River Laboratories International CRL	403 M	$ 176.94	-2.0 %	$ 8.77 B	USA
Danaher Corporation DHR	750 M	$ 193.78	-2.18 %	$ 138 B	USA
Interpace Biosciences IDXG	425 K	$ 2.2	-	$ 9.73 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	354 M	$ 132.72	0.35 %	$ 21.1 B	USA
Fulgent Genetics FLGT	24.9 M	$ 16.13	-0.25 %	$ 488 M	USA
Medpace Holdings MEDP	27.2 M	$ 515.65	-0.56 %	$ 14.9 B	USA
Guardant Health GH	39.7 M	$ 85.7	0.99 %	$ 10.7 B	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	38.3 K	$ 2.83	-3.41 %	$ 91.8 K	USA
Biomerica BMRA	87 K	$ 2.2	4.27 %	$ 5.05 M	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	488 M	$ 115.58	-0.79 %	$ 9.53 B	Irlanda
Laboratory Corporation of America Holdings LH	681 M	$ 266.36	-0.14 %	$ 22.2 B	USA
Celcuity CELC	167 K	$ 125.25	1.44 %	$ 5.86 B	USA
Lantheus Holdings LNTH	70.1 M	$ 83.92	-0.02 %	$ 5.66 B	USA
Myriad Genetics MYGN	53.7 M	$ 5.0	-3.66 %	$ 463 M	USA
NeoGenomics NEO	36.1 M	$ 8.16	-5.99 %	$ 1.05 B	USA
Neogen Corporation NEOG	119 M	$ 9.24	-1.91 %	$ 2 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 191.46	0.02 %	$ 21.3 B	USA
ENDRA Life Sciences NDRA	44 K	$ 5.17	0.58 %	$ 4.07 M	USA
National Research Corporation NRC	7.62 M	$ 17.62	-1.23 %	$ 394 M	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA
Natera NTRA	16.7 M	$ 196.11	-5.35 %	$ 19.3 B	USA
OpGen OPGN	175 K	-	-16.95 %	$ 1.54 M	USA
PerkinElmer PKI	405 M	-	-0.91 %	$ 14.7 B	USA